A randomized controlled trial of a probiotic, VSL# 3, on gut transit and symptoms in diarrhoea‐predominant irritable bowel syndrome
M Camilleri, S McKinzie, MB Lempke… - Alimentary …, 2003 - Wiley Online Library
Aim: To investigate the effects of a probiotic formulation, VSL# 3, on gastrointestinal transit
and symptoms of patients with Rome II irritable bowel syndrome with predominant …
and symptoms of patients with Rome II irritable bowel syndrome with predominant …
A randomized controlled trial of a probiotic, VSL# 3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome
HJ Kim, M Camilleri, S McKinzie… - Alimentary …, 2003 - pubmed.ncbi.nlm.nih.gov
Aim To investigate the effects of a probiotic formulation, VSL# 3, on gastrointestinal transit
and symptoms of patients with Rome II irritable bowel syndrome with predominant …
and symptoms of patients with Rome II irritable bowel syndrome with predominant …
[引用][C] A randomized controlled trial of a probiotic, VSL# 3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome
HJ KIM, M CAMILLERI, S MCKINZIE… - Alimentary …, 2003 - pascal-francis.inist.fr
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant
irritable bowel syndrome CNRS Inist Pascal-Francis CNRS Pascal and Francis …
irritable bowel syndrome CNRS Inist Pascal-Francis CNRS Pascal and Francis …
A randomized controlled trial of a probiotic, VSL# 3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome
HJ Kim, M Camilleri, S McKinzie… - Alimentary …, 2003 - mayoclinic.elsevierpure.com
Aim: To investigate the effects of a probiotic formulation, VSL# 3, on gastrointestinal transit
and symptoms of patients with Rome II irritable bowel syndrome with predominant …
and symptoms of patients with Rome II irritable bowel syndrome with predominant …
A randomized controlled trial of a probiotic, VSL# 3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome.
HJ Kim, M Camilleri, S McKinzie… - Alimentary …, 2003 - europepmc.org
Aim To investigate the effects of a probiotic formulation, VSL# 3, on gastrointestinal transit
and symptoms of patients with Rome II irritable bowel syndrome with predominant …
and symptoms of patients with Rome II irritable bowel syndrome with predominant …
A randomized controlled trial of a probiotic, VSL# 3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome.
HJ Kim, M Camilleri, S Mckinzie… - Alimentary …, 2003 - search.ebscohost.com
Aim: To investigate the effects of a probiotic formulation, VSL# 3, on gastrointestinal transit
and symptoms of patients with Rome II irritable bowel syndrome with predominant …
and symptoms of patients with Rome II irritable bowel syndrome with predominant …
A randomized controlled trial of a probiotic, VSL# 3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome
HJ Kim, M Camilleri, S McKinzie, MB Lempke… - Alimentary …, 2003 - elibrary.ru
Aim: To investigate the effects of a probiotic formulation, VSL# 3, on gastrointestinal transit
and symptoms of patients with Rome II irritable bowel syndrome with predominant …
and symptoms of patients with Rome II irritable bowel syndrome with predominant …
A randomized controlled trial of a probiotic, VSL# 3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome.
HJ Kim, M Camilleri, S Mckinzie, MB Lempke… - 2003 - cabidigitallibrary.org
Aim: To investigate the effects of a probiotic formulation, VSL# 3, on gastrointestinal transit
and symptoms of patients with Rome II irritable bowel syndrome with predominant …
and symptoms of patients with Rome II irritable bowel syndrome with predominant …